Since Mus81 inhibition dramatically improves the sensitivity of EPI in HCC cells as well as animal xenograft model, the dose of EPI to achieve equivalent response could be significantly decreased in condition of Mus81 being suppressed, which is obviously helpful to diminish the dose‐dependent toxicity effects of EPI in HCC chemotherapy. Here, MUS81 is linked to hepatocellular carcinoma.